Columbia, Md. (PRWEB) September 12, 2011
DSM Nutritional Products, based in Switzerland, today announced the formation of Nutritional Lipids that will combine Martek’s algal DHA omega-3 and ARA omega-6 products and DSM Nutritional Products’ polyunsaturated fatty acid (PUFAs) portfolio, making DSM the world’s leading innovator and supplier in this category. Nutritional Lipids will focus on developing and positioning innovative nutritional lipids products. The business will leverage Martek’s technology and market position in the U.S., and DSM Nutritional Products’ unique global asset footprint, marketing and sales, and premix network to capture significant global growth opportunities and accelerate international expansion.
In a large and growing body of scientific evidence nutritional lipids have shown significant health benefits and support brain, eye and cardiovascular health throughout life. Leading experts around the world have noted that healthy lipids such as DHA, EPA and ARA are important nutrients for health throughout the life cycle, yet many consumers do not include enough in their daily diets. The nutritional lipids category of health and nutrition ingredients is science-based, fast growing and in an early stage of development, with significant growth opportunities. Products from DSM's Nutritional Lipids portfolio can already be found in more than 400 brands of infant formula, nutritional supplements, functional foods and animal feeds sold worldwide.
Peter A. Nitze, who joined Martek in 2005 and held the position of COO at the time of the acquisition, will lead Nutritional Lipids as President and will be based in Columbia, Md. Steve Dubin, Martek’s CEO at the time of acquisition, will also be assuming a new role at DSM to be announced at a later date. David Abramson, Martek’s President at the time of acquisition, has been appointed Senior Executive Advisor for DSM Nutritional Products.
DSM – Bright Science. Brighter Living. ™
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver annual net sales of about € 9 bn. The company is listed on NYSE Euronext. http://www.dsm.com.
For More Information:
tel. +1 443 542 2116
mobile + 1 443 710 9373
This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.